Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Abdulaziz ALHamad"'
Autor:
Jawaher Ansari, Sumaya Alhelali, Zakariya Albinmousa, Ashraf Farrag, Arwa M. Ali, Mai Abdelgelil, Abdulaziz Alhamad, Ghormallah Alzahrani, Asif Ansari, John Glaholm
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 861-870 (2018)
Intracardiac metastases in the absence of inferior vena cava involvement is a rare occurrence in patients with metastatic renal cell carcinoma (mRCC). There is limited evidence regarding the efficacy and safety of standard treatment modalities for mR
Externí odkaz:
https://doaj.org/article/80269a36d8f34809be9741d4ecbbb569
Publikováno v:
Case Reports in Immunology, Vol 2018 (2018)
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is un
Externí odkaz:
https://doaj.org/article/58b51453788244a585a8b5a46898bed7
Autor:
Wael Alturaiki, Abdulaziz Alhamad, Muath Alturaiqy, Shabir Ahmad Mir, Danish Iqbal, Abdul Aziz Bin Dukhyil, Mohammed Alaidarous, Bader Alshehri, Suliman A Alsagaby, Sami G. Almalki, Fayez Alghofaili, Ranjay K. Choudhary, Saeedah Almutairi, Saeed Banawas, Bandar Alosaimi, Ayman Mubarak
Publikováno v:
International Journal of Rheumatic Diseases. 25:1013-1019
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disorder which mainly affects small joints, occurs most commonly in middle-aged adults, and can be fatal in severe cases. The exact etiology of RA remains unknown. However, uncontrolled exp
Autor:
Bander Alharbi, Muneera AlMajed, Mohamed Almeziny, Nagwa Ibrahim, Muneerah Alzouman, Abdulaziz Alhamad, Huda Aldossary, Sumliman AlRashed
Publikováno v:
Global Journal of Medical Therapeutics. 3:1-5
Immune checkpoint inhibitors such as nivolumab and pembrolizumab are approved by Food and Drug Administration for patients diagnosed with metastatic solid tumors with high microsatellite instability (MSI) or mismatch repair deficient (dMMR). The prog
Autor:
Mohammed Alghamdi, Shouki Bazarbashi, Mervat Mahrous, Omar Alshaer, Ahmed Mostafa Gad, Mohamed Aseafan, Mai Abdelgelil, Redhwan Mohammed Alshabi, Hosam Ali Alghanmi, Nasser Ahmed Naser, Husam Al Hariri, Abdulaziz ALHamad, Khalid Al-Saleh, Nashwa Abdel-Aziz, Sherif Elsamany
Publikováno v:
Journal of oncology. 2022
Background. The outcome of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) beyond the second-line has not been studied in Saudi Arabia. Therefore, this multicenter retrospective analysis was
Autor:
Anoud Abdulaziz Alhamad
Publikováno v:
World Journal of English Language. 12:514
The study theorizes that multiculturalism is a grounded commonality and a contact zone of postcolonial literature and translation. It concentrates on some of the common cultural aspects in the fields. Therefore, this study aims to emphasize the multi
Autor:
Ashraf Farrag, Abdulaziz Alhamad, Esam Murshid, Mai Abdelgelil, Hidayath Ansari, Arwa M. Ali, Jawaher Ansari, Muhammad Ali, Syed A. Hussain, John Glaholm
Publikováno v:
Molecular and Clinical Oncology
Checkpoint inhibitors (CPIs), such as nivolumab, have transformed the treatment paradigm for patients with metastatic non-small cell lung cancer (mNSCLC) and metastatic renal cell carcinoma (mRCC). The combination of CPIs and radiotherapy (RT) consti
Autor:
Ghormallah Alzahrani, Asif Ansari, Abdulaziz Alhamad, Ashraf Farrag, Mai Abdelgelil, Zakariya Albinmousa, Jawaher Ansari, Arwa M. Ali, Sumaya Alhelali, John Glaholm
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 3, Pp 861-870 (2018)
Case Reports in Oncology
Case Reports in Oncology
Intracardiac metastases in the absence of inferior vena cava involvement is a rare occurrence in patients with metastatic renal cell carcinoma (mRCC). There is limited evidence regarding the efficacy and safety of standard treatment modalities for mR
Publikováno v:
Global Journal of Medical Therapeutics. 2
The COVID-19 pandemic led to several critical challenges that impacted the healthcare system worldwide. Many guidelines have been developed internationally and nationally aiming to minimize the risk of infection and its sequential complications. Canc
Publikováno v:
Case Reports in Immunology
Case Reports in Immunology, Vol 2018 (2018)
Case Reports in Immunology, Vol 2018 (2018)
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is un